tiprankstipranks
Santhera Pharmaceuticals Holding (SPHDF)
OTHER OTC:SPHDF
US Market
SPHDF
Santhera Pharmaceuticals Holding
RESEARCH TOOLSreports
Want to see SPHDF full AI Analyst Report?

Santhera Pharmaceuticals Holding (SPHDF) Income Statement

40 Followers

Santhera Pharmaceuticals Holding Income Statement

Last quarter (Q4 2025), Santhera Pharmaceuticals Holding's total revenue was CHF53.17M, a decrease of -46.53% from the same quarter last year. In Q4, Santhera Pharmaceuticals Holding's net income was CHF-10.40M. See Santhera Pharmaceuticals Holding’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Dec 23Mar 23Dec 21
Total Revenue
CHF 77.19MCHF 39.12MCHF 103.41MCHF 7.47MCHF -1.59M
Gross Profit
CHF 14.47MCHF 22.96MCHF 100.18MCHF 3.88MCHF -5.36M
Operating Expenses
CHF 52.28MCHF 56.69MCHF 31.34MCHF 55.86MCHF 51.53M
Depreciation and Amortization
CHF 5.69MCHF 5.65MCHF 3.04MCHF 3.65MCHF 3.72M
EBITDA
CHF -32.13MCHF -15.89MCHF 79.17MCHF -46.78MCHF -34.57M
Operating Income
CHF -37.82MCHF -33.38MCHF 68.84MCHF -51.98MCHF -56.89M
Other Income/Expenses
CHF -11.23MCHF -8.28MCHF -14.02MCHF -18.64MCHF 2.17M
Pretax Income
CHF -49.05MCHF -41.66MCHF 54.82MCHF -70.62MCHF -54.72M
Net Income
CHF -49.24MCHF -41.97MCHF 54.78MCHF -71.08MCHF -55.53M
Per Share Metrics
Basic EPS
CHF -3.78CHF -3.69CHF 5.18CHF -11.67CHF -16.25
Diluted EPS
CHF -3.78CHF -3.69CHF 5.01CHF -11.67CHF -16.25
Weighted Average Shares Outstanding
 13.01M 11.38M 10.58M 6.09M 3.42M
Weighted Average Shares Outstanding (Diluted)
 13.01M 11.38M 10.92M 6.09M 3.42M
Currency in CHF

Santhera Pharmaceuticals Holding Earnings and Revenue History